<![CDATA[ImmunAbs Inc. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=48174>Wed, 29 Apr 2026 17:13:47 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis]]>https://www.newswire.co.kr/newsRead.php?no=1012602Thu, 05 Jun 2025 17:20:00 +0900<![CDATA[이뮨앱스, 중증근무력증 치료를 위한 새로운 보체 C5 억제제 IM-101의 FDA 2상 IND 승인 발표]]>https://www.newswire.co.kr/newsRead.php?no=1012603Thu, 05 Jun 2025 17:20:00 +0900